Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases Article

Mehta, MP, Rodrigus, P, Terhaard, CHJ et al. (2003). Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases . JOURNAL OF CLINICAL ONCOLOGY, 21(13), 2529-2536. 10.1200/JCO.2003.12.122

Industry Collaboration International Collaboration

cited authors

  • Mehta, MP; Rodrigus, P; Terhaard, CHJ; Rao, A; Suh, J; Roa, W; Soukami, L; Bezjak, A; Leibenhaut, M; Komaki, R; Schultz, C; Timmerman, R; Curran, W; Smith, J; Phan, SC; Miller, RA; Renschler, MF

sustainable development goals

authors

publication date

  • July 1, 2003

webpage

published in

keywords

  • CHEMOTHERAPY
  • CLINICAL-TRIAL
  • Life Sciences & Biomedicine
  • MALIGNANT GLIOMA
  • ONCOLOGY-GROUP
  • Oncology
  • PALLIATION
  • PARTITIONING ANALYSIS RPA
  • PHASE-III
  • PROGNOSTIC FACTORS
  • RADIOTHERAPY
  • Science & Technology
  • TEXAPHYRIN

Location

  • SAN DIEGO, CALIFORNIA

Digital Object Identifier (DOI)

publisher

  • AMER SOC CLINICAL ONCOLOGY

start page

  • 2529

end page

  • 2536

volume

  • 21

issue

  • 13